MFH vs AIXI vs BBAI vs FTFT

For growth investors, Mercurity Fintech Holding Inc.

(MFH) is the stronger pick with 125. 9% revenue growth year-over-year, versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). Analysts rate BigBear. ai Holdings, Inc. (BBAI) a "Hold" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Mercurity Fintech Holding Inc.

(MFH) delivered a total return of -20. 5%, compared to -99. 3% for Future FinTech Group Inc. (FTFT). Over 10 years, the gap is even starker: BBAI returned -57. 6% versus FTFT's -98. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Xiao-I Corporation (AIXI) is the lower-risk stock at 0.

94β versus BigBear. ai Holdings, Inc. 's 3. 31β — meaning BBAI is approximately 251% more volatile than AIXI relative to the S&P 500. On balance sheet safety, BigBear. ai Holdings, Inc. (BBAI) carries a lower debt/equity ratio of 4% versus 32% for Mercurity Fintech Holding Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Mercurity Fintech Holding Inc.

(MFH) is pulling ahead at 125. 9% versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). On earnings-per-share growth, the picture is similar: Future FinTech Group Inc. grew EPS 85. 2% year-over-year, compared to 35. 4% for BigBear. ai Holdings, Inc.. Over a 3-year CAGR, AIXI leads at 29. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Xiao-I Corporation (AIXI) is the more profitable company, earning -20.

6% net margin versus -450. 1% for Mercurity Fintech Holding Inc. — meaning it keeps -20. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AIXI leads at -18. 3% versus -888. 0% for FTFT. At the gross margin level — before operating expenses — AIXI leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Xiao-I Corporation (AIXI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

94)). Future FinTech Group Inc. (FTFT) carries a higher beta of 2. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AIXI: -98. 6%, FTFT: -98. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MFH (Financial Services) and AIXI (Technology) and BBAI (Technology) and FTFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MFH is a small-cap high-growth stock; AIXI is a small-cap high-growth stock; BBAI is a mid-cap quality compounder stock; FTFT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.